{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:49:56Z","timestamp":1695487796749},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008669","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:13:26Z","timestamp":1511378006000},"page":"e8669","source":"Crossref","is-referenced-by-count":7,"title":["Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient"],"prefix":"10.1097","volume":"96","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Bastida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Cano-Mozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Lopez-Cadenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Eduardo","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Merch\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Santos-Mont\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gonz\u00e1lez-Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Africa","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Angel","family":"Torres-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mart\u00edn-Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Pab\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Ramon","family":"Gonz\u00e1lez-Porras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-35-20210309","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1756-0500-3-161","article-title":"Consensus recommendations for the diagnosis and treatment of acquired hemophilia A","volume":"3","author":"Collins","year":"2010","journal-title":"BMC Res Notes"},{"key":"R2-35-20210309","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R3-35-20210309","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"R4-35-20210309","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2298\/SARH10S1064E","article-title":"Acquired haemophilia syndrome: pathophysiology and therapy","volume":"138","author":"Elezovic","year":"2010","journal-title":"Srp Arh Celok Lek"},{"key":"R5-35-20210309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12185-017-2210-8","article-title":"Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan","volume":"106","author":"Ogawa","year":"2017","journal-title":"Int J Hematol"},{"key":"R6-35-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00277-009-0887-3","article-title":"Acquired haemophilia caused by non-haemophilic factor VIII gene variants","volume":"89","author":"Tiede","year":"2010","journal-title":"Ann Hematol"},{"key":"R7-35-20210309","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1471-0528.2012.03469.x","article-title":"Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry","volume":"119","author":"Tengborn","year":"2012","journal-title":"BJOG"},{"key":"R8-35-20210309","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"R9-35-20210309","first-page":"329","article-title":"Acquired hemophilia A as a cause of recurrent bleeding into the pleural cavity - case report and literature review","volume":"11","author":"Wojtys","year":"2014","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"R10-35-20210309","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1160\/TH14-12-1062","article-title":"Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A","volume":"114","author":"Batty","year":"2015","journal-title":"Thromb Haemost"},{"key":"R11-35-20210309","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0034-1390004","article-title":"Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges","volume":"40","author":"Tiede","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"R12-35-20210309","first-page":"345","article-title":"Acquired hemophilia with inhibitors presenting as an emergency: misinterpretation of clotting results during direct oral anticoagulation","volume":"111","author":"Sumnig","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"R13-35-20210309","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/jth.13304","article-title":"Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01\/2010 study","volume":"14","author":"Werwitzke","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R14-35-20210309","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MBC.0000000000000582","article-title":"Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry","volume":"27","author":"Kessler","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R15-35-20210309","first-page":"96","article-title":"Acquired hemophilia: a critical bleeding syndrome","volume":"89","author":"Baudo","year":"2004","journal-title":"Haematologica"},{"key":"R16-35-20210309","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12185-011-0968-7","article-title":"Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature","volume":"95","author":"Muzaffar","year":"2012","journal-title":"Int J Hematol"},{"key":"R17-35-20210309","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.athoracsur.2011.08.044","article-title":"Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences","volume":"92","author":"Chatterjee","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R18-35-20210309","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014\u200aAHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R19-35-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4330\/wjc.v7.i2.65","article-title":"Percutaneous left atrial appendage closure: technical aspects and prevention of periprocedural complications with the watchman device","volume":"7","author":"Mobius-Winkler","year":"2015","journal-title":"World J Cardiol"},{"key":"R20-35-20210309","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ccd.22499","article-title":"Transcatheter closure of the left atrial appendage: initial experience with the Amplatzer cardiac plug device","volume":"76","author":"Rodes-Cabau","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R21-35-20210309","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jcmg.2015.02.002","article-title":"Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography","volume":"8","author":"Wunderlich","year":"2015","journal-title":"JACC Cardiovasc Imag"},{"key":"R22-35-20210309","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/MBC.0b013e3283551102","article-title":"Acquired haemophilia: an often overlooked cause of bleeding\u2014experience from a Hungarian tertiary care centre","volume":"23","author":"Arokszallasi","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R23-35-20210309","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","article-title":"Acquired hemophilia A: a review of recent data and new therapeutic options","volume":"22","author":"Franchini","year":"2017","journal-title":"Hematology"},{"key":"R24-35-20210309","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0035-1569068","article-title":"The judicious use of recombinant factor VIIa","volume":"42","author":"Goodnough","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"R25-35-20210309","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0268-960X(15)30006-0","article-title":"Safety update on the use of recombinant activated factor VII in approved indications","volume":"29","author":"Neufeld","year":"2015","journal-title":"Blood Rev"},{"key":"R26-35-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry","volume":"120","author":"Baudo","year":"2012","journal-title":"Blood"},{"key":"R27-35-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"Collins","year":"2012","journal-title":"Blood"},{"key":"R28-35-20210309","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study","volume":"125","author":"Tiede","year":"2015","journal-title":"Blood"},{"key":"R29-35-20210309","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood-2015-09-672774","article-title":"Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01\/2010 study","volume":"127","author":"Tiede","year":"2016","journal-title":"Blood"},{"key":"R30-35-20210309","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0049-3848(12)70019-1","article-title":"Acquired hemophilia in malignancy","volume":"129","author":"Reeves","year":"2012","journal-title":"Thromb Res"},{"key":"R31-35-20210309","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1080\/10428190701203962","article-title":"Acquired hemophilia in chronic lymphocytic leukemia","volume":"48","author":"Mahipal","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R32-35-20210309","first-page":"381e1","article-title":"Update of the Grupo Espanol de Leucemia Linfocitica Cronica clinical guidelines of the management of chronic lymphocytic leukemia.","volume":"148","author":"Garcia-Marco","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"R33-35-20210309","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.critrevonc.2007.12.004","article-title":"Acquired factor VIII inhibitors in oncohematology: a systematic review","volume":"66","author":"Franchini","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"R34-35-20210309","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5858\/2000-124-0730-AHIPWH","article-title":"Acquired hemophilia in patients with hematologic malignancies","volume":"124","author":"Sallah","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"R35-35-20210309","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MBC.0000000000000370","article-title":"Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma: a case report and review of the literature","volume":"26","author":"Porru","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R36-35-20210309","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3109\/10428194.2015.1023722","article-title":"Eradication of acquired hemophilia associated with indolent non-Hodgkin lymphoma by a disease specific treatment","volume":"56","author":"Mariotti","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R37-35-20210309","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1053\/j.jvca.2013.10.015","article-title":"Successful perioperative management of severe bleeding from undiagnosed acquired factor VIII inhibitors","volume":"29","author":"Barbara","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R38-35-20210309","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/08998280.2017.11929642","article-title":"Treatment of chronic lymphocytic leukemia\/small lymphocytic lymphoma presenting simultaneously with acquired hemophilia and warm autoimmune hemolytic anemia","volume":"30","author":"Williams","year":"2017","journal-title":"Proc (Bayl Univ Med Cent"},{"key":"R39-35-20210309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MBC.0000000000000209","article-title":"Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia: a case report and review of the literature","volume":"26","author":"Murphy","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R40-35-20210309","first-page":"496","article-title":"Development of acquired hemophilia A during treatment of multiple myeloma with lenalidomide","volume":"56","author":"Saburi","year":"2015","journal-title":"Rinsho Ketsueki"},{"key":"R41-35-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12288-013-0266-z","article-title":"Management of acquired haemophilia bleed in the backdrop of multiple myeloma","volume":"31","author":"Ross","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R42-35-20210309","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bjh.14185","article-title":"Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A","volume":"178","author":"McFadyen","year":"2017","journal-title":"Br J Haematol"},{"key":"R43-35-20210309","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4274\/tjh.2016.0146","article-title":"Disappearance of acquired hemophilia A after complete remission in a multiple myeloma patient","volume":"34","author":"Innao","year":"2017","journal-title":"Turk J Haematol"},{"key":"R44-35-20210309","first-page":"109","article-title":"Bortezomib: potential key role in the treatment of multiple myeloma-related acquired hemophilia A","volume":"43","author":"Br\u00e1s","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"R45-35-20210309","first-page":"262","article-title":"A rare case of acquired hemophilia A associated with myelodysplastic syndrome","volume":"5","author":"Raval","year":"2012","journal-title":"Int J Clin Exp Med"},{"key":"R46-35-20210309","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1111\/hae.12714","article-title":"Chronic myelomonocytic leukaemia associated with acquired haemophilia A: case report and literature review","volume":"21","author":"Liang","year":"2015","journal-title":"Haemophilia"},{"key":"R47-35-20210309","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/JBM.S37631","article-title":"Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation","volume":"3","author":"Imashuku","year":"2012","journal-title":"J Blood Med"},{"key":"R48-35-20210309","first-page":"2192","article-title":"Primary myelofibrosis complicated by acquired hemophilia A and subsequent development of acute myeloid leukemia","volume":"54","author":"Kuroda","year":"2013","journal-title":"Rinsho Ketsueki"},{"key":"R49-35-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13256-016-0897-4","article-title":"Myelofibrosis and acquired hemophilia A: a case report","volume":"10","author":"Wrobel","year":"2016","journal-title":"J Med Case Rep"},{"key":"R50-35-20210309","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1365-2516.2003.00806.x","article-title":"An acquired factor VIII inhibitor in association with a myeloproliferative\/myelodysplastic disorder presenting with severe subcutaneous haemorrhage","volume":"9","author":"Biss","year":"2003","journal-title":"Haemophilia"},{"key":"R51-35-20210309","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.21949","article-title":"Acquired hemophilia: we now see it with myeloproliferative neoplasms","volume":"86","author":"Kremyanskaya","year":"2011","journal-title":"Am J Hematol"},{"key":"R52-35-20210309","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000335132","article-title":"Acquired hemophilia A in a patient with essential thrombocythemia","volume":"127","author":"Mori","year":"2012","journal-title":"Acta Haematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:41:55Z","timestamp":1620960115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711270-00035"}},"subtitle":["A case report, and a review of acquired hemophilia A-related hematological malignancies"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":52,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008669","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}